Initially, the drug sensitivity test of cisplatin did not show a significant difference between wild‐type and HACE1–/– HGC27 cells (Figure S2), which is probably due to a low expression of HACE1 as a tumour suppressor gene in cancer cells.15 This evidence concerns the gene HACE1 and cancer.